CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014
Beginning Balance	$ 24,701
Stock based compensation	5,814,963
Exchange warrants for common stock	100
Net loss	(6,608,862)
Ending Balance, Amount	846,845
Series B Convertible Preferred Stock
Net assets outstanding at time the reverse merger was completed, Shares	400,000
Net assets outstanding at time the reverse merger was completed, Amount	400
Conversion of Series B Convertible Preferred to common stock, Shares	(341,327)
Conversion of Series B Convertible Preferred to common stock, Amount	(341)
Series C Convertible Preferred Stock
Issuance of Series C - 3,750,000 Private Placement Units, Shares	3,750,000
Issuance of Series C - 3,750,000 Private Placement Units, Amount	3,750
Common Stock
Net assets outstanding at time the reverse merger was completed, Shares	10,762,881
Net assets outstanding at time the reverse merger was completed, Amount	10,763
Common stock issued for cash, Shares	51,758,563
Common stock issued for cash, Amount	51,759
Issuance of Series C - 3,750,000 Private Placement Units, Amount
Issuance cost - Series C
Warrant liability - 1,875,000 warrants issued in connection with Private Placement Units
Stock based compensation
Conversion of Series B Convertible Preferred to common stock, Shares	34,132,700
Conversion of Series B Convertible Preferred to common stock, Amount	34,132
Net loss
Additional Paid-In Capital
Net assets outstanding at time the reverse merger was completed, Amount	(11,163)
Common stock issued for cash, Amount	(43,759)
Issuance of Series C - 3,750,000 Private Placement Units, Amount	1,871,250
Issuance cost - Series C	62,000
Warrant liability - 1,875,000 warrants issued in connection with Private Placement Units	(227,239)
Stock based compensation	3,567,163
Reclassification of derivative liability warrant	22,282
Conversion of Series B Convertible Preferred to common stock, Amount	(33,791)
Net loss
Retained Earnings / Accumulated Deficit
Net assets outstanding at time the reverse merger was completed, Amount
Common stock issued for cash, Amount
Issuance of Series C - 3,750,000 Private Placement Units, Amount
Issuance cost - Series C
Warrant liability - 1,875,000 warrants issued in connection with Private Placement Units
Stock based compensation
Conversion of Series B Convertible Preferred to common stock, Amount
Net loss	$ (4,019,364)